CSPC PHARMACEUTICAL - PHARMA'S RECOMBINANT HERPES ZOSTER VACCINE (SYS6052) OBTAINS FDA CLINICAL TRIAL APPROVAL IN U.S.

Reuters · 1d ago

Please log in to view news